Table 1.
LB incidence and prevalence ratios compared with total seropositive cases.
| Study | Seropositive prevalence (SP) | LB prevalence (P) | Ratio LB Prev/SP | LB incidence (I) | Ratio LB Ins/SP | |
|---|---|---|---|---|---|---|
| Arteaga (2007) | 14.6% | 3.6% | 24.7% | nd | nd | |
| Fahrer (1998) | 26.0% | nd | nd | 0.80% | 3.1% | |
| Faulde (2014) | 9.1% | nd | nd | 0.70% | 7.7% | |
| Guy (1989) | 25.0% | 5.0% | 20.0% | nd | nd | |
| Kuiper (1991) | 19.7% | 6.0% | 30.5% | nd | nd | |
| Kuiper (1993) | 28.0% | 5.5% | 19.7% | nd | nd | |
| Müller (2012) | 9.1% | nd | nd | 0.26% | 2.9% | |
| Willhelmsson (2016) | 39.0% | nd | nd | 2.00% | 5.1% | |
| Mean | 23.7% | 4.69% | ||||